Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,808 | -46,444 | -25,341 | -114,527 | -90,986 |
| Depreciation Amortization | 1,038 | 869 | 445 | 2,060 | 1,537 |
| Accounts payable and accrued liabilities | -1,256 | 1,983 | -256 | 170 | -40 |
| Other Working Capital | -6,060 | -2,566 | 1,455 | -9,666 | -3,940 |
| Other Operating Activity | 14,575 | 6,055 | 3,421 | 20,728 | 15,384 |
| Operating Cash Flow | $-50,511 | $-40,103 | $-20,276 | $-101,235 | $-78,045 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 501 | -12 | -12 | -622 | -394 |
| Investing Cash Flow | $501 | $-12 | $-12 | $-622 | $-394 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 44,487 | N/A |
| Debt Repayment | -5,049 | N/A | N/A | -47,610 | N/A |
| Common Stock Issued | 24,342 | 36 | 36 | 84,778 | 79,916 |
| Other Financing Activity | -272 | -235 | -235 | 0 | 0 |
| Financing Cash Flow | $19,021 | $-199 | $-199 | $81,655 | $79,916 |
| Exchange Rate Effect | -50 | -1 | 17 | -454 | -1,022 |
| Beginning Cash Position | 49,098 | 49,098 | 49,098 | 69,754 | 69,754 |
| End Cash Position | 18,059 | 8,783 | 28,628 | 49,098 | 70,209 |
| Net Cash Flow | $-31,039 | $-40,315 | $-20,470 | $-20,656 | $455 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,511 | -40,103 | -20,276 | -101,235 | -78,045 |
| Capital Expenditure | -59 | -12 | -12 | -622 | -394 |
| Free Cash Flow | -50,570 | -40,115 | -20,288 | -101,857 | -78,439 |